TruSight Oncology 500: Enabling Comprehensive Genomic Profiling and Biomarker Reporting with Targeted SequencingChen Zhao, Sven Bilke, Jenn Lococo et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 38
925P Analytical performance of a next-generation sequencing (NGS) assay kit for assessing homologous recombination deficiency (HRD) from solid tumor samplesL. Liu, J. Day, Kyria Roessler et al.|Annals of Oncology|2022Cited by 3
Clinical and analytical accuracy of a 523 gene panel next-generation sequencing (NGS) assay on formalin-fixed paraffin-embedded (FFPE) solid tumour samplesIna L. Deras, Janel Dockter, Tingting Du et al.|Annals of Oncology|2019Cited by 0